These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35. Topiramate for the treatment of cocaine addiction: a randomized clinical trial. Johnson BA; Ait-Daoud N; Wang XQ; Penberthy JK; Javors MA; Seneviratne C; Liu L JAMA Psychiatry; 2013 Dec; 70(12):1338-46. PubMed ID: 24132249 [TBL] [Abstract][Full Text] [Related]
36. Atomoxetine improved attention in children and adolescents with attention-deficit/hyperactivity disorder and dyslexia in a 16 week, acute, randomized, double-blind trial. Wietecha L; Williams D; Shaywitz S; Shaywitz B; Hooper SR; Wigal SB; Dunn D; McBurnett K J Child Adolesc Psychopharmacol; 2013 Nov; 23(9):605-13. PubMed ID: 24206099 [TBL] [Abstract][Full Text] [Related]
37. Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence. Montoya ID; Gorelick DA; Preston KL; Schroeder JR; Umbricht A; Cheskin LJ; Lange WR; Contoreggi C; Johnson RE; Fudala PJ Clin Pharmacol Ther; 2004 Jan; 75(1):34-48. PubMed ID: 14749690 [TBL] [Abstract][Full Text] [Related]
40. Effect of atomoxetine on Tanner stage sexual development in children and adolescents with attention deficit/hyperactivity disorder: 18-month results from a double-blind, placebo-controlled trial. Trzepacz PT; Spencer TJ; Zhang S; Bangs ME; Witte MM; Desaiah D Curr Med Res Opin; 2011; 27 Suppl 2():45-52. PubMed ID: 21973230 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]